{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:45:00Z","timestamp":1773060300993,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T00:00:00Z","timestamp":1487548800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12282-017-0761-4","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T01:50:44Z","timestamp":1487555444000},"page":"702-707","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Relationship between alcohol metabolism and chemotherapy-induced emetic events in breast cancer patients"],"prefix":"10.1007","volume":"24","author":[{"given":"Toshitaka","family":"Uomori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiya","family":"Horimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Mogushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsue","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"issue":"8","key":"761_CR1","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/bjc.1997.507","volume":"76","author":"M Boer-Dennert de","year":"1997","unstructured":"de Boer-Dennert M, de Wit R, Schmitz PI, Djontono J, Beurden V, Stoter G, et al. Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer. 1997;76(8):1055\u201361.","journal-title":"Br J Cancer"},{"issue":"27","key":"761_CR2","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1200\/JCO.2006.05.6382","volume":"24","author":"B Bloechl-Daum","year":"2006","unstructured":"Bloechl-Daum B, Deuson RR, Mavros P, Hansen M, Herrstedt J. Delayed nausea and vomiting continue to reduce patients\u2019 quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment. J Clin Oncol. 2006;24(27):4472\u20138.","journal-title":"J Clin Oncol"},{"issue":"5","key":"761_CR3","first-page":"701","volume":"33","author":"H Ishiguro","year":"2006","unstructured":"Ishiguro H, Nambu Y, Maekawa Y, Adachi S. Evidence-based management of nausea and vomiting. Jpn J Cancer Chemother. 2006;33(5):701\u20136.","journal-title":"Jpn J Cancer Chemother"},{"issue":"2","key":"761_CR4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00520-004-0718-y","volume":"13","author":"SM Grunberg","year":"2005","unstructured":"Grunberg SM, Osoba D, Hesketh PJ, Gralla RJ, Borjeson S, Rapoport BL, et al. Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity\u2014an update. Support Care Cancer. 2005;13(2):80\u20134.","journal-title":"Support Care Cancer"},{"issue":"11","key":"761_CR5","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1200\/JCO.2003.05.164","volume":"21","author":"P-B Tremblay","year":"2003","unstructured":"Tremblay P-B, Kaiser R, Sezer O, R\u00f6sler N, Schelenz C, Possinger K, et al. Variations in the 5-hydroxytryptamine type 3B receptor gene as predictors of the efficacy of antiemetic treatment in cancer patients. J Clin Oncol. 2003;21(11):2147\u201355.","journal-title":"J Clin Oncol"},{"issue":"10","key":"761_CR6","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1007\/s00520-013-1843-2","volume":"21","author":"A Molassiotis","year":"2013","unstructured":"Molassiotis A, Stamataki Z, Kontopantelis E. Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting. Support Care Cancer. 2013;21(10):2759\u201367.","journal-title":"Support Care Cancer"},{"issue":"1","key":"761_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00520-010-1073-9","volume":"20","author":"DL Hilarius","year":"2012","unstructured":"Hilarius DL, Kloeg PH, van der Wall E, van den Heuvel JJG, Gundy CM, Aaronson NK. Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study. Support Care Cancer. 2012;20(1):107\u201317.","journal-title":"Support Care Cancer"},{"issue":"6","key":"761_CR8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s00520-010-0899-5","volume":"19","author":"DG Warr","year":"2011","unstructured":"Warr DG, Street JC, Carides AD. Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of phase 3 trial of aprepitant in patients receiving adriamycin\u2013cyclophosphamide-based chemotherapy. Support Care Cancer. 2011;19(6):807\u201313.","journal-title":"Support Care Cancer"},{"issue":"9","key":"761_CR9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00520-009-0737-9","volume":"18","author":"PJ Hesketh","year":"2010","unstructured":"Hesketh PJ, Aapro M, Street JC, Carides AD. Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy. Support Care Cancer. 2010;18(9):1171\u20137.","journal-title":"Support Care Cancer"},{"issue":"6","key":"761_CR10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/cas.12146","volume":"104","author":"I Sekine","year":"2013","unstructured":"Sekine I, Segawa Y, Kubota K, Saeki T. Risk factors of chemotherapy-induced nausea and vomiting: index for personalized antiemetic prophylaxis. Cancer Sci. 2013;104(6):711\u20137.","journal-title":"Cancer Sci"},{"issue":"5","key":"761_CR11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1254\/fpj.108.233","volume":"108","author":"M Minami","year":"1996","unstructured":"Minami M, Endo T, Hirafuji M. Role of serotonin in emesis. Folia Pharmacol Jpn. 1996;108(5):233\u201375.","journal-title":"Folia Pharmacol Jpn"},{"issue":"3","key":"761_CR12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/hmg\/ddn372","volume":"18","author":"S Macgregor","year":"2009","unstructured":"Macgregor S, Lind PA, Bucholz KK, Hansell NK, Madden PAF, Richter MM, et al. Associations of ADH and ALDH2 gene variation with self report alcohol reactions, consumption and dependence: an integrated analysis. Hum Mol Genet. 2009;18(3):580\u201393.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"761_CR13","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/01.ftd.0000179840.78762.33","volume":"27","author":"TL Wall","year":"2005","unstructured":"Wall TL. Genetic associations of alcohol and aldehyde dehydrogenase with alcohol dependence and their mechanisms of action. Ther Drug Monit. 2005;27(6):700\u20133.","journal-title":"Ther Drug Monit"},{"issue":"1","key":"761_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1530-0277.1991.tb00532.x","volume":"15","author":"N Enomoto","year":"1991","unstructured":"Enomoto N, Takase S, Yasuhara M, Takada A. Acetaldehyde metabolism in different aldehyde dehydrogenase-2 genotypes. Alcohol Clin Exp Res. 1991;15(1):141\u20134.","journal-title":"Alcohol Clin Exp Res"},{"issue":"4","key":"761_CR15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02267061","volume":"97","author":"S Higuchi","year":"1996","unstructured":"Higuchi S, Muramatsu T, Matsushita S, Murayama M, Hayashida M. Polymorphisms of ethanol-oxidizing enzymes in alcoholics with inactive ALDH2. Hum Genet. 1996;97(4):431\u20134.","journal-title":"Hum Genet"},{"issue":"3","key":"761_CR16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nmeth1007","volume":"4","author":"Y Mitani","year":"2007","unstructured":"Mitani Y, Lezhava A, Kawai Y, Kikuchi T, Oguchi-Katayama A, Kogo Y, et al. Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology. Nat Meth. 2007;4(3):257\u201362.","journal-title":"Nat Meth"},{"issue":"11","key":"761_CR17","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/0006-2952(92)90326-E","volume":"43","author":"PA Dockham","year":"1992","unstructured":"Dockham PA, Lee M-O, Sladek NE. Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde. Biochem Pharmacol. 1992;43(11):2453\u201369.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"761_CR18","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0090-9556(25)06708-X","volume":"15","author":"Rikans LE","year":"1987","unstructured":"LE Rikans. The oxidation of acrolein by rat liver aldehyde dehydrogenases. relation to allyl alcohol hepatotoxicity. Drug Metab Disposition. 1987;15(3):356\u201362.","journal-title":"Drug Metab Disposition"},{"issue":"5","key":"761_CR19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0024-3205(94)00646-6","volume":"55","author":"A Helander","year":"1994","unstructured":"Helander A, Walzer C, Beck O, Balant L, Borg S, von Wartburg J. Influence of genetic variation in alcohol and aldehyde dehydrogenase on serotonin metabolism. Life Sci. 1994;55(5):359\u201366.","journal-title":"Life Sci"},{"issue":"Supplement 1","key":"761_CR20","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S1353-8020(13)70019-1","volume":"20","author":"JA Doorn","year":"2014","unstructured":"Doorn JA, Florang VR, Schamp JH, Vanle BC. Aldehyde dehydrogenase inhibition generates a reactive dopamine metabolite autotoxic to dopamine neurons. Parkinsonism Relat Disord. 2014;20(Supplement 1):S73\u20135.","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-017-0761-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-017-0761-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-017-0761-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T14:13:35Z","timestamp":1749996815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-017-0761-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["761"],"URL":"https:\/\/doi.org\/10.1007\/s12282-017-0761-4","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,20]]}}}